Junhui Yu
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Inflammasome and immune disorders 5
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Xuejun Sun (13 shared papers)Zilu Chen (8 shared papers)Jianbao Zheng (10 shared papers)Jing Guo (5 shared papers)Jie Qi (4 shared papers)Yunhua Wu (2 shared papers)Kai Wang (2 shared papers)Shan Li (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)International Journal of Oncology (2 papers)Optics & Laser Technology (2 papers)Cell Cycle (2 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Junhui Yu
23 papers receiving 683 citations
Junhui Yu's Hit Papers
Peers
Comparison fields: 5 of 78
- Nephrology 106
- Cancer Research 127
- Molecular Biology 533
- Immunology 159
- Molecular Medicine 25
Countries citing papers authored by Junhui Yu
This map shows the geographic impact of Junhui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Yu more than expected).
Fields of papers citing papers by Junhui Yu
This network shows the impact of papers produced by Junhui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Yu. The network helps show where Junhui Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhui Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells Hit paper breakdown → | 2019 | 383 |
| 2 | 2021 | 56 | |
| 3 | 2018 | 27 | |
| 4 | 2018 | 26 | |
| 5 | 2023 | 24 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 23 | |
| 8 | 2017 | 21 | |
| 9 | 2023 | 16 | |
| 10 | 2021 | 14 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2018 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2022 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2024 | 1 |
About Junhui Yu
Junhui Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pathology and Forensic Medicine, having authored 25 papers that have together received 685 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers), Cancer-related molecular mechanisms research (3 papers), Laser-Matter Interactions and Applications (3 papers), Peptidase Inhibition and Analysis (2 papers), Orbital Angular Momentum in Optics (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Nephrology (106 citations), Cancer Research (127 citations), Molecular Biology (533 citations), Immunology (159 citations) and Molecular Medicine (25 citations). Junhui Yu has collaborated with scholars based in China and South Korea. Frequent co-authors include Xuejun Sun, Zilu Chen, Jianbao Zheng, Jing Guo, Jie Qi, Yunhua Wu, Kai Wang, Shan Li, Zhengshui Xu and Qi Gao. Their work appears in journals such as Cell Death and Disease, International Journal of Oncology, Optics & Laser Technology, Cell Cycle and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.